Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Correction: TransAlta Swings to Q3 Adjusted Net Earnings, Revenue Falls

Correction: TransAlta Swings to Q3 Adjusted Net Earnings, Revenue Falls

MT newswireMT newswire2026/11/03 11:53
07:53 AM EST, 11/03/2026 (MT Newswires) -- (Corrects to show the year-earlier figure was a loss in first paragraph.) TransAlta (TA.TO, TAC) reported Q3 adjusted net earnings of CA$0.18 per share compared with a loss of CA$0.02 per share a year earlier. Analysts polled by FactSet expected CA$0.08. Revenue for the quarter ended Sept. 30 was CA$536 million compared with CA$615 million a year earlier, said the company on Tuesday. "With our strong year to date performance, we are confident in achieving our 2026 outlook range," said Chief Executive Officer Joel Hunter.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss